← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 1, 2003Last known activity
Dec 12, 2023
Timeline
1990s
- Jun 1, 1997
Mary Crowley Cancer Center— Founded
Drugs by trial phase (24 distinct, 29 trials)
Phase 2 (14 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Colonic Neoplasms
- Colorectal Neoplasms
- Endometrial Neoplasms
- Fallopian Tube Neoplasms
- Glioma
- Liver Neoplasms
- Lung Neoplasms
- Melanoma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Peritoneal Neoplasms
- Sarcoma
- Sarcoma, Ewing
- Uterine Cervical Neoplasms
- Uterine Neoplasms
Recent trials (31)
- NCT05861895Overall official - principal investigatorPhase 1Dec 12, 2023
- NCT03096340Overall official - principal investigatorPhase 1Mar 23, 2017
- NCT02725489Lead sponsorPhase 2Jun 3, 2016
- NCT02725489Overall official - principal investigatorPhase 2Jun 3, 2016
- NCT02310464Overall official - principal investigatorPhase 1Dec 1, 2015
- NCT02340117Overall official - principal investigatorPhase 2Jan 1, 2015
- NCT01978964Overall official - principal investigatorPhase 1Nov 1, 2012
- NCT01505166Overall official - principal investigatorPhase 2Mar 1, 2012
- NCT01551745Overall official - principal investigatorPhase 2Mar 1, 2012
- NCT01505153Overall official - principal investigatorPhase 1Feb 1, 2012
- NCT01504542Overall official - principal investigatorPhase 2Dec 1, 2011
- NCT01453361Overall official - principal investigatorPhase 2Oct 1, 2011
- NCT01188499Overall official - principal investigatorPhase 1/Phase 2Oct 1, 2010
- NCT01041235Overall official - principal investigatorPhase 1Dec 1, 2009
- NCT01061840Overall official - principal investigatorPhase 1Dec 1, 2009
Details
- Founded
- Dallas, TX, US Jun 1, 1997
- Last known activity
- Dec 12, 2023